Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2‐macroglobulin and tau: A population‐based autopsy study

References

• Gustavsson A., Jahr H., Tobiassen R., Jacobson D. R., Sletten K., Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 1995; 73: 703–8
   PubMed Web of Science ®Google Scholar
• Pitkanen P., Westermark P., Cornwell G. G 3rd. Senile systemic amyloidosis. Am J Pathol 1984; 117: 391–9
   PubMed Web of Science ®Google Scholar
• Johansson B., Westermark P. Senile systemic amyloidosis: a clinico‐pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991; 32: 83–92
   PubMed Web of Science ®Google Scholar
• Ng B., Connors L. H., Davidoff R., Skinner M., Falk R. H. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain‐associated amyloidosis. Arch Intern Med 2005; 165: 1425–9
   PubMed Web of Science ®Google Scholar
• Stone M. J. Amyloidosis: a final common pathway for protein deposition in tissues. Blood 1990; 75: 531–45
   PubMed Web of Science ®Google Scholar
• O'Hara C. J., Falk R. H. The diagnosis and typing of cardiac amyloidosis. Amyloid 2003; 10: 127–9
   PubMed Web of Science ®Google Scholar
• Kyle R. A., Spittell P. C., Gertz M. A., Li C. Y., Edwards W. D., Olson L. J., et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996; 101: 395–400
   PubMed Web of Science ®Google Scholar
• Hughes S. E., McKenna W. J. New insights into the pathology of inherited cardiomyopathy. Heart 2005; 91: 257–64
   Google Scholar
• Cornwell G. G 3rd., Murdoch W. L., Kyle R. A., Westermark P., Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983; 75: 618–23
   PubMed Web of Science ®Google Scholar
• Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., et al. Apolipoprotein E, dementia, and cortical deposition of beta‐amyloid protein. N Engl J Med 1995; 333: 1242–7
   PubMed Web of Science ®Google Scholar
• Myllykangas L., Polvikoski T., Sulkava R., Verkkoniemi A., Crook R., Tienari P. J., et al. Genetic association of alpha2‐macroglobulin with Alzheimer's disease in a Finnish elderly population. Ann Neurol 1999; 46: 382–90
   Google Scholar
• Myllykangas L., Polvikoski T., Sulkava R., Verkkoniemi A., Tienari P., Niinisto L., et al. Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over. Neurosci Lett 2000; 292: 195–8
   PubMed Web of Science ®Google Scholar
• Myllykangas L., Wavrant‐De Vrieze F., Polvikoski T., Notkola I. L., Sulkava R., Niinisto L., et al. Chromosome 21 BACE2 haplotype associates with Alzheimer's disease: a two‐stage study. J Neurol Sci 2005; 236: 17–24
   Google Scholar
• Tanskanen M., Lindsberg P. J., Tienari P. J., Polvikoski T., Sulkava R., Verkkoniemi A., et al. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and ApoE genotype. Neuropathol Appl Neurobiol 2005; 31: 589–99
   PubMed Web of Science ®Google Scholar
• Myllykangas L., Polvikoski T., Sulkava R., Notkola I. L., Rastas S., Verkkoniemi A., et al. Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population‐based neuropathological study. Ann Med 2001; 33: 486–92
   PubMed Web of Science ®Google Scholar
• Nurmi M. H., Bishop M., Strain L., Brett F., McGuigan C., Hutchison M., et al. The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand 2003; 108: 374–8
   PubMed Web of Science ®Google Scholar
• Baker M., Graff‐Radford D., Wavrant DeVrieze F., Graff‐Radford N., Petersen R. C., Kokmen E., et al. No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease. Neurosci Lett 2000; 285: 147–9
   Google Scholar
• Myllykangas L., Polvikoski T., Reunanen K., Wavrant‐De Vrieze F., Ellis C., Hernandez D., et al. ApoE epsilon3‐haplotype modulates Alzheimer beta‐amyloid deposition in the brain. Am J Med Genet 2002; 114: 288–91
   PubMedGoogle Scholar
• Myers A. J., Kaleem M., Marlowe L., Pittman A. M., Lees A. J., Fung H. C., et al. The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet 2005; 14: 2399–404
   PubMed Web of Science ®Google Scholar
• Jacobson D. R., Alves I. L., Saraiva M. J., Thibodeau S. N., Buxbaum J. N. Transthyretin Ser 6 gene frequency in individuals without amyloidosis. Hum Genet 1995; 95: 308–12
   PubMed Web of Science ®Google Scholar
• Westermark P., Bergstrom J., Solomon A., Murphy C., Sletten K. Transthyretin‐derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 2003; 10 Suppl 1: 48–54
   PubMedGoogle Scholar
• Vinters H., Wang Z., Secor D. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996; 6: 179–95
   PubMed Web of Science ®Google Scholar
• Tanskanen M., Kiuru‐Enari S., Tienari P., Polvikoski T., Verkkoniemi A., Rastas S., et al. Senile systemic amyloidosis, cerebral amyloid angiopathy, and dementia in a very old Finnish population. Amyloid 2006; 13: 164–9
   PubMed Web of Science ®Google Scholar
• Rebeck G. W., Harr S. D., Strickland D. K., Hyman B. T. Multiple, diverse senile plaque‐associated proteins are ligands of an apolipoprotein E receptor, the alpha 2‐macroglobulin receptor/low‐density‐lipoprotein receptor‐related protein. Ann Neurol 1995; 37: 211–7
   PubMed Web of Science ®Google Scholar
• Muller D., Roessner A., Rocken C. Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and alpha 2‐macroglobulin in cases of generalized AA‐ and AL amyloidosis. Virchows Arch 2000; 437: 521–7
   PubMed Web of Science ®Google Scholar
• Campistol J. M., Shirahama T., Abraham C. R., Rodgers O. G., Sole M., Cohen A. S., et al. Demonstration of plasma proteinase inhibitors in beta 2‐microglobulin amyloid deposits. Kidney Int 1992; 42: 915–23
   PubMed Web of Science ®Google Scholar
• Adler V., Davidowitz E., Tamburi P., Rojas P., Grossman A. α2‐Macroglobulin is a potential facilitator of prion protein transformation. Amyloid 2007; 14: 1–10
   PubMed Web of Science ®Google Scholar
• Blacker D., Wilcox M. A., Laird N. M., Rodes L., Horvath S. M., Go R. C., et al. Alpha‐2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998; 19: 357–60
   PubMed Web of Science ®Google Scholar
• Liao A., Nitsch R. M., Greenberg S. M., Finckh U., Blacker D., Albert M., et al. Genetic association of an alpha2‐macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet 1998; 7: 1953–6
   Google Scholar
• Pirskanen M., Alafuzoff I., Hiltunen M., Mannermaa A., Helisalmi S., Lehtovirta M., et al. An association between a subset of Finnish late‐onset Alzheimer's disease and alpha2‐macroglobulin. Neurogenetics 2001; 3: 171–2
   Google Scholar
• Goedert M., Jakes R. Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta 2005; 1739: 240–50
   PubMed Web of Science ®Google Scholar
• Askanas V., Engel W. K., Bilak M., Alvarez R. B., Selkoe D. J. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol 1994; 144: 177–87
   PubMed Web of Science ®Google Scholar
• Ballatore C., Lee V. M., Trojanowski J. Tau‐mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007; 8: 663–72
   PubMed Web of Science ®Google Scholar
• Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez‐Tur J., et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999; 8: 711–5
   PubMed Web of Science ®Google Scholar
• Stefansson H., Helgason A., Thorleifsson G., Steinthorsdottir V., Masson G., Barnard J., et al. A common inversion under selection in Europeans. Nat Genet 2005; 37: 129–37
   PubMed Web of Science ®Google Scholar
• Zaccai J., Ince P., Brayne C. Population‐based neuropathological studies of dementia: design, methods and areas of investigation—a systematic review. BMC Neurol 2006; 6: 2
   Google Scholar